We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the ...

NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within NVIDIA's AI portfolio, especially in the fledgling AI biotech sector ...

Faster access to medicines matters to patients. For many New Zealanders, pharmaceuticals are life or death, or the difference ...

Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic value. Dive into the future of drug discovery and clinical development ...

Looking ahead, the integration of AI in pharmaceutical R&D is expected to deepen. Emerging technologies such as quantum computing and advanced robotics will further enhance AI's capabilities.

How to get rich? The single best way is to live a long time, ideally working much of that time while amassing savings that ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...

The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...

The company is implementing a workforce reduction of ~30%. This, along with other cost-saving measures, is expected to ...

--BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence and machine learning to enable the successful development of pharmaceuticals and biologics ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) became a popular AI stock following NVIDIA’s $50 million investment in the biotech firm in 2024.

A new artificial intelligence (AI) platform is poised to radically change the way the pharmaceutical industry develops new drugs while dramatically cutting the cost of medical trials. The ...